STAT Plus: Bristol Myers Squibb to buy MyoKardia for $13 billion
MEL EVANS/AP
The pharma giant said it will purchase MyoKardia, an 8-year-old developer of an experimental heart drug, for $13.1 billion in cash.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario